drugset / Trial / NCT06291363

Impact of Administration of Esmolol on Nociception Level-guided Control of Nociception.

NCT06291363

Phase 4 Recruiting 64 enrolled Ciusss de L'Est de l'Île de Montréal
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study aims to evaluate esmolol's perfusion impact during induction and maintenance of general anesthesia, using Nociception-Level-guided control of nociception, in adult patients undergoing laparoscopic and lower abdominal surgery, on intraoperative remifentanil consumption and postoperative pain in the Post-Anesthesia Care Unit.

Timeline

Start
2024-04-16
Primary completion
2025-03-03
Completion
2025-03-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Esmolol Other / unclassified 20 ug/kg Intravenous